NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that, in compliance with the Florida Business Corporations Act, and its governing corporate documents and rules relating thereto, the Company’s board will take immediate steps to begin increasing the number of members serving on its Board of Directors (“Board”)  to seven, with a majority of such resulting Board being “independent” members. Additionally, the Company will promptly begin implementing more stringent and improved corporate governance (“Governance”) protocols and policies.  We intend to implement and complete these steps by March 31, 2021 or as soon as practicable.   In addition to appointing qualified and experienced new board members, the Company has also committed to focus on diversity in appointing one or more members to our Board.  As required under applicable SEC disclosure rules, we will timely report any new board appointments as they occur either via Form 8-K or such other quarterly or annual report, as the case may be.

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *